BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30157958)

  • 1. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair.
    Guo X; He D; Zhang E; Chen J; Chen Q; Li Y; Yang L; Yang Y; Zhao Y; Wang G; He J; Cai Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):205. PubMed ID: 30157958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.
    Yang L; Yu Y; Kang R; Yang M; Xie M; Wang Z; Tang D; Zhao M; Liu L; Zhang H; Cao L
    Leuk Lymphoma; 2012 Feb; 53(2):315-22. PubMed ID: 21864037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma.
    Gao D; Lv AE; Li HP; Han DH; Zhang YP
    J Cell Biochem; 2017 Oct; 118(10):3341-3348. PubMed ID: 28295550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
    Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
    Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
    [No Abstract]   [Full Text] [Related]  

  • 7. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
    Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
    J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
    Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
    Wang L; Zhang H; Sun M; Yin Z; Qian J
    Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
    Wu Y; Wang H
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29205703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of HMGB1 inhibits cell proliferation and induces apoptosis in hemangioma via downregulation of AKT pathway.
    Pan C; Wang Y; Qiu MK; Wang SQ; Liu YB; Quan ZW; Ou JM
    J Biol Regul Homeost Agents; 2017; 31(1):41-49. PubMed ID: 28337869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.
    Xiao Y; Sun L; Fu Y; Huang Y; Zhou R; Hu X; Zhou P; Quan J; Li N; Fan XG
    BMC Cancer; 2017 Dec; 17(1):857. PubMed ID: 29246127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
    Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
    Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of HMGB1 in Radioresistance of Bladder Cancer.
    Shrivastava S; Mansure JJ; Almajed W; Cury F; Ferbeyre G; Popovic M; Seuntjens J; Kassouf W
    Mol Cancer Ther; 2016 Mar; 15(3):471-9. PubMed ID: 26719575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells.
    Wang Z; Wang X; Li J; Yang C; Xing Z; Chen R; Xu F
    Mol Med Rep; 2016 Jul; 14(1):1026-32. PubMed ID: 27220399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma.
    Roy M; Liang L; Xiao X; Peng Y; Luo Y; Zhou W; Zhang J; Qiu L; Zhang S; Liu F; Ye M; Zhou W; Liu J
    Theranostics; 2016; 6(12):2209-2224. PubMed ID: 27924158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma.
    Du L; Liu W; Aldana-Masangkay G; Pozhitkov A; Pichiorri F; Chen Y; Rosen ST
    J Exp Clin Cancer Res; 2022 Jan; 41(1):8. PubMed ID: 34983615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion.
    Su Z; Wang T; Zhu H; Zhang P; Han R; Liu Y; Ni P; Shen H; Xu W; Xu H
    Immunobiology; 2015 May; 220(5):539-44. PubMed ID: 25578401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.